Top 20 biopharma companies’ market caps rise 1.7% over 2024 amid policy
Eli Lilly achieved the largest market capitalisation growth of 32.4% to $733bn in 2024, driven by strong demand for Mounjaro ...
Gilead Sciences, Inc. (GILD): AI Partnerships Enhancing Biopharmaceutical Advancements
We recently published a list of 10 AI News and Ratings You Should Not Miss. In this article, we are going to take a look at ...
Business Insider6h
Teva Pharmaceutical (TEVA) Gets a Buy from Argus Research
Hellweg covers the Healthcare sector, focusing on stocks such as Eli Lilly & Co, Gilead Sciences, and Viatris. Currently, the analyst consensus on Teva Pharmaceutical is a Strong Buy with an average ...
Pharmabiz6h
Cognizant and Gilead expand partnership to drive greater value through advanced technology applications
Cognizant and Gilead expand partnership to drive greater value through advanced technology applications: Teaneck, New Jersey Friday, January 31, 2025, 14:00 Hrs [IST] Cognizant ha ...
Bernstein Sticks to Its Buy Rating for Gilead Sciences (GILD)
Bernstein analyst Courtney Breen maintained a Buy rating on Gilead Sciences (GILD – Research Report) yesterday and set a price target of ...
Gilead Sciences Inc. stock outperforms competitors on strong trading day
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...